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The signaling paradigm for cytokine
receptors consists of ligand binding
to the extracellular domains of cell-
surface-exposed receptors. This first
even leads to either dimerization or
conformational change of a preformed
inactive dimer (1,2), which in turn
leads to reciprocal activation of Janus
kinase proteins (JAK) that are ap-
pended to the cytosolic juxtamembrane
regions of receptors. Once JAKs
become activated they phosphorylate
tyrosines on cytosolic domains of
receptors and on JAKs themselves.
Phosphorylated tyrosines attract SH2-
containing proteins such as members
of the signal transducer and activator
of transcription (STAT) proteins,
which becomes themselves substrates
of JAKs (3). In phosphorylated form,
STATs dimerize and translocate to the
nucleus where they regulate gene
expression (3). In addition to JAKs,
cytokine receptors attract adaptors
that connect to the MAP-kinase and
ras/PI-30-kinase/Akt pathways (2).
This process, which physiologically
occurs only in the presence of cyto-
kines, can be activated constitutively
if JAKs or receptors are mutated and
therefore signal in the absence of
ligand, as is the case for several can-
cers, most notably the myeloprolifera-
tive neoplasms (MPNs) (4).
In this model, cytokine receptor
signaling starts from the cell surface,http://dx.doi.org/10.1016/j.bpj.2014.10.029
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internalization of receptors, first to
endosomes and eventually JAK-stimu-
lated transport to lysosomes for degra-
dation. Internalization is regarded as
one major path to signal termination.
Certain receptors can be cleaved in
the cytosolic domains by proteasomes
(5), either on the surface or while
en route to lysosomes. In revised
signaling models it has been shown
that prolonged signaling via certain
pathways requires internalization, sug-
gesting that once initiated at the cell
surface, certain pathways continue to
be activated in intracellular compart-
ments. This was the case for G-CSFR,
where certain signaling pathways,
as well as lysine ubiquitination and
redox-controlled phosphatase activ-
ities, are linked to the signaling endo-
some (6).
A provocative and elegant biophysi-
cal study by Gandhi et al. (7) in this
issue of the Biophysical Journal brings
forward data that shift this paradigm.
By using fluorescence cross-correla-
tion spectroscopy on functional, but
truncated receptors in HEK293 cells,
authors show that heteromeric com-
plexes involving interleukin 4 receptor
(IL4R) subunits (especially Type-II
complexes of IL4Ra and IL13Ra1
coupled to either IL4 or IL13) exhibit
very low (100-fold lower than con-
ventional receptors) intersubunit affin-
ity. An elegant approach was used
whereby one subunit was fused to
green fluorescence protein and the
other contained a His tag to which a
fluorescent chemical can bind, inde-
pendently from cytokine binding (7).
This system allowed the determi-
nation of intramembrane dissociation
constants, which are highly relevant
for receptor function and cannot be
extrapolated from the different affin-
ities of ligands for soluble recombinant
extracellular domains. The weak affin-
ity for receptor subunit dimerization
makes it impossible for cell surface
complexes, which authors show can
be formed by ligand, to induce signifi-
cant levels of signaling at the surfaceand implies that mechanismsmust exist
for concentration of active receptors to
reach a critical mass for signaling.
Authors show that this mechanism
is represented by internalization in
cortical endosomes, which are closely
located to the plasma membrane. Of
interest, internalization is constitutive,
not requiring ligand binding.
Thus, a novel model is introduced
where ligand-binding and conforma-
tional changes (or hetero-dimerization
changes) at the cell surface do not
suffice for IL4R signaling via any
of the types of complexes that are
formed. Constitutive internalization
into cortical adjacent endosomes places
ligand-activated receptors in clusters
that then can trigger sufficient signaling
to induce biologic effects. Remarkably,
the conformational changes induced
by ligand must be stable during inter-
nalization into endosomes, leading to
strong JAK-STAT activation on the
cytosolic side of the endosomal mem-
brane due to receptor clustering. In
other receptor systems such as erythro-
poietin or growth hormone receptors,
which are preformed dimers in the
membrane, it has been shown that
conformational changes leading to acti-
vation require both rotation- and scis-
sorlike movements (8–10). In contrast,
IFN receptor subunits appear to be
essentially monomeric (11), similar to
IL4R receptor subunits (12), but activa-
tion requires ligand-induced heterome-
rization and possibly conformational
changes leading JAK activation. It is
not clear whether ligand binding in the
case of IL4R subunits only induces
the required conformational changes
and JAK activation in cortical endo-
somes, or to a low extent below the
threshold of signaling at the cell surface
as well, where heteromerization is
shown to occur.
There are certain potential caveats
with this work. One is that IL4Ra
needed to be truncated in the cytosolic
domain for getting sufficient cell
2480 Constantinescusurface localization for measurements.
The truncation preserves the cytosolic
box-1, required for JAK binding and
activation, but eliminates the cytosolic
tyrosine that upon phosphorylation,
recruits STAT6. In the physiological
setting, binding of STAT6 might stabi-
lize weak dimers and therefore could
increase intersubunit affinity at the
surface. Another potential caveat is
that certain transfected receptors might
not have been coupled to JAK proteins
and it would be necessary to assess the
effect of different levels of JAK pro-
teins on intersubunit affinity. Neverthe-
less, the pathway presented shows
that endosomal clustering can drive
signaling for IL4R complexes. This
opens new perspectives for the study
of cytokine receptor signaling and
points again to endosomes as major
hubs of signaling. It will be very inter-
esting to assess whether endosomal
signaling is also essential for modified
IL4 cytokines (superkines) that have
been designed to exhibit increased
affinity for recruiting IL2Rg or
IL13Ra1 second-chain subunits (13).
Finally, changes in ligand-receptor af-
finity in endosomes have been created
by mutagenesis to enhance biologic
potency of cytokines such as IL2 or
G-CSF. This is done by taking advan-
tage of residues that, when mutated,
only decrease affinity for receptors at
acidic pH and not at the neutral pH
at the cell surface. They then stimu-
late recycling of ligands, especially
because acidic pH appears to stabilize
IL2 and G-CSF (14). It will be of major
interest to test the precise pH of theseBiophysical Journal 107(11) 2479–2480cortical signaling endosomes, to deter-
mine whether ligand recycling occurs
in vivo and investigate how cortical
endosomal clustering might regulate
signaling by other heteromeric and
homomeric cytokine receptors.
One implication of this work also
concerns the efforts to inhibit patho-
logic JAKs in cancer. Starting with
the discovery of JAK2 V617F as a
highly prevalent somatic acquired mu-
tation in human MPNs, several JAK2
inhibitors have been tested and one
has been approved for treatment of
MPNs (4). All available JAK inhibitors
in the clinic are type-I ATP competi-
tive, targeting JAK kinase domains in
the active conformation, which allows
rapid recovery for short half-life com-
pounds. Although it is expected that
many cytokine receptors would signal
from both the cell surface and endo-
somes, having cortical endosomes
cluster receptor-JAK complexes could
make inhibition less efficient, given
that not all JAKs in such clusters
need to be active for signaling to occur.REFERENCES
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